The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
July 7th 2025
The new formulation contains little IgA, reducing possible risks associated with infusion in patients with primary immunodeficiency.
Calaspargase Pegol-mknl Granted FDA Approval for Pediatric, Young Adult Patients With ALL
December 21st 2018The FDA has approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals) as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) in pediatric and young adult patients, aged 1 month to 21 years.
Read More